Drug Shortage Report for TEVA-LENOLTEC NO. 4
Report ID | 3121 |
Drug Identification Number | 00621463 |
Brand name | RATIO-LENOLTEC NO 4 |
Common or Proper name | LENOLTEC |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE |
Strength(s) | 300MG 60MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-05-01 |
Actual start date | |
Estimated end date | 2017-05-30 |
Actual end date | 2017-07-20 |
Shortage status | Resolved |
Updated date | 2017-09-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-09-05 | French | Compare |
v4 | 2017-09-05 | English | Compare |
v3 | 2017-05-02 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v1 | 2017-03-17 | English | Compare |
Showing 1 to 5 of 5